- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02261792
Spontaneous Intracranial Hypotension Treatment "SIHT" (SIHT)
Parallel Randomised Open Blind Evaluation Study of the Efficacy of 20° Trendelenburg Position During 24 Hours After Epidural Blood Patch in the Treatment of Spontaneous Intracranial Hypotension
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Various treatments have been used for patient with spontaneous intracranial hypotension, but there is not definite approach. Some patients, fortunately, improve spontaneously. Bed rest and increased fluid intake have been advocate. The effectiveness of the caffeine has been shown in some studies, but durable beneficial effect is doubtful. The efficacy of steroids has not been established. However, although there have been no controlled studies, autologous epidural blood patch (EBP) can be considered the treatment of choice for patients. The success rate of EBP for a post lumbar puncture headache is about 90%, but for SIH, is very less about 50% after the first one and 77% after the second. The amount of blood injected must be sufficient. On the other hand, the leak is usually located on dorsal, above the prolonged rest must be respected. One study, have demonstrated, without randomization, a success rate of 90% with a prolonged Trendelenburg after EBP. We decided to do this study, to confirm a superiority of a 24 hours prolonged Trendelenburg position.
It's a monocentric study of parallel randomized open blind groups. Patients will be recruited by investigators in our headache emergency room. If the diagnose of SIH is confirmed (orthostatic headache from more than 5 days and less than 28 days with a normal MRI or with sign of SIH) study will be proposed.
After a signed information, the patients will be randomized in 2 groups, the investigator is blind of the randomized arm of patient
- EBP with 24 hours bed rest
- EBP with 24 hours Trendelenburg position
V1: inclusion V2 : 24 hours before EBP (headache, associated symptoms, HIT6) V3 : randomization and EBP V4 : first evaluation 30 minutes after standing (headaches, associated symptoms) V5 : phone evaluation (safety) D7 V6 : Evaluation at D15 (headache, associated symptoms, safety) V7 : Evaluation at D30 (headache, associated symptoms, control cerebral MRI, HIT6, safety) V8 : last evaluation D60 (headache, associated symptoms,HIT6 safety)
Collection of 2nd EBP, 3rd EBP, 4th EBP throughout the study up to J 92 maximum
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75010
- Lariboisiere Hospital - Centre Urgences Céphalées (CUC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years or more
- No contraindication for BPE
- Severe or moderate headache within 15 min standing, mild or no headache after 15 min bed rest
- Headache from 5 to 28 days
- Normal or evidence of low CSF on MRI
- Signed informed consent
Exclusion Criteria:
- Known dural leak in the previous 2 months the onset of headache
- Abnormal MRI
- First BPE for SIH
- The patient has participated in another clinical trial than can interact with the evaluation
- Contraindication of Trendelenburg position
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: A : 24 hours bed rest
24 hours bed rest
|
24 hours bed rest after EBP
Other Names:
Autologous Epidural Blood Patch
Other Names:
|
|
Experimental: B : 24 hours Trendelenburg position
24 hours Trendelenburg position
|
Autologous Epidural Blood Patch
Other Names:
Trendelenburg position
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recovery at Day 1 without relapse at Day 15
Time Frame: Day 1
|
V4: first evaluation 30 minutes after standing (headaches, associated symptoms) V6 : Evaluation at D15 (headache, associated symptoms, safety)
|
Day 1
|
|
Recovery at Day 1 without relapse at Day 15
Time Frame: day 15
|
V4: first evaluation 30 minutes after standing (headaches, associated symptoms) V6 : Evaluation at D15 (headache, associated symptoms, safety)
|
day 15
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
2d EBP and other EBP
Time Frame: day 7, 15, 30 and 60
|
Number of patients requires a treatment with a second BP at any time of study (withdrawal study)
|
day 7, 15, 30 and 60
|
|
Associated symptoms
Time Frame: day 1, 15, 30 and 60
|
Disappearance of associated symptoms
|
day 1, 15, 30 and 60
|
|
Headache
Time Frame: day 1,15, 30 and 60
|
Pain scores, localisation and type of persistent headache at day 1,15, 30 and 60
|
day 1,15, 30 and 60
|
|
subdural hematoma surgery
Time Frame: day 7, 15, 30 and 60
|
Number of patients requires a surgery for life-threatening acute SDH
|
day 7, 15, 30 and 60
|
|
cerebral MRI
Time Frame: day 30
|
results of D30 control MRI, compared to baseline MRI
|
day 30
|
|
medullar MRI
Time Frame: day 60
|
results of baseline medullar MRI and the link between leak and patient recovery
|
day 60
|
|
Epidural Blood Patch
Time Frame: day 60
|
Volume of blood and localisation of injection / statistical data related with recovery
|
day 60
|
Collaborators and Investigators
Investigators
- Principal Investigator: Caroline ROOS, MD, Assistance Publique - Hôpitaux de Paris
Publications and helpful links
General Publications
- Ferrante E, Arpino I, Citterio A, Wetzl R, Savino A. Epidural blood patch in Trendelenburg position pre-medicated with acetazolamide to treat spontaneous intracranial hypotension. Eur J Neurol. 2010 May;17(5):715-9. doi: 10.1111/j.1468-1331.2009.02913.x. Epub 2009 Dec 29.
- Sencakova D, Mokri B, McClelland RL. The efficacy of epidural blood patch in spontaneous CSF leaks. Neurology. 2001 Nov 27;57(10):1921-3. doi: 10.1212/wnl.57.10.1921.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P111118
- 2013-AO1017-38 (Other Identifier: IDRCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spontaneous Intracranial Hypotension
-
Beijing Tiantan HospitalWithdrawnSpontaneous Intracranial Hypotension
-
Beijing Tiantan HospitalNot yet recruitingSpontaneous Intracranial Hypotension
-
Duke UniversitySiemens HealthineersRecruiting
-
Mayo ClinicRecruitingSpontaneous Intracranial HypotensionUnited States
-
University Health Network, TorontoRecruitingSpontaneous Intracranial HypotensionCanada
-
Yonsei UniversityNot yet recruitingSpontaneous Intracranial Hypotension
-
Cedars-Sinai Medical CenterSuspendedHyperprolactinemia | Spontaneous Intracranial HypotensionUnited States
-
Danish Headache CenterEnrolling by invitationIntracranial Hypotension | Spontaneous Intracranial Hypotension | Post-Lumbar Puncture HeadacheDenmark
-
Beijing Tiantan HospitalRecruitingVenous Sinus Stenosis | Idiopathic Intracranial HypotensionChina
-
Tang-Du HospitalRecruitingSpontaneous Intracranial Hemorrhage | Spontaneous Intraparenchymal Cerebral Hemorrhage | Spontaneous Cerebellar HaemorrhageChina
Clinical Trials on 24 hours bed rest
-
Federal University of São PauloCompletedAcute Coronary SyndromeBrazil
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
Science and Research Centre KoperUniversity of Trieste; University of Padova; University of Pavia; University of... and other collaboratorsCompletedMuscular AtrophySlovenia
-
University of New MexicoCompletedInsulin Resistance | Type 2 DiabetesUnited States
-
AdventHealth Translational Research InstituteRecruitingType 2 Diabetes | Aging | Muscle Atrophy | Sedentary Behavior | Pre-diabetesUnited States
-
Heidelberg UniversityTerminated
-
National Taiwan University HospitalEnrolling by invitationCSF Leakage | Adenoma PituitaryTaiwan
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustCompletedSleep Disturbance | Muscle Atrophy | Weightlessness | Astronaut-Bone Demineralisation SyndromeUnited Kingdom
-
Tong ZhuNot yet recruitingDeep Vein Thrombosis | Deep Venous Insufficiency
-
Instituto de Investigacion Sanitaria La FeCompleted